TBET Financials Tuesday, July 15, 2014 6:47:55 PM
Post# of 3
Tibet Pharmaceuticals, Inc.
Period Ending Dec 31, 2010
Total Revenue 32,365
Cost of Revenue 16,190
Gross Profit 16,175
Operating Expenses
Research and Development -
Sales, General and Admin. 2,860
Non-Recurring Items -
Other -
Operating Income 13,315
Income From Continuing Operations
Add'l Income/Expense Items 15
Earnings Before Interest and Tax 13,330
Interest Expense 188
Earnings Before Tax 13,142
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations 13,142
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income 13,142
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders 13,142